Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 7

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 7
---
 should carefully consider the risk factors 
 described in the section titled “Risk Factors” beginning on page S-5 of this prospectus supplement as well as the risks              
 identified in documents that are incorporated by reference in this prospectus supplement.                                            |

The number of shares of our ordinary shares to be issued and outstanding after this offering is based on 37,156,382 shares of our ordinary shares issued and outstanding as of August 8, 2025, and excludes:

| ● | Up                                                                                                                                   
 to 5,000,000 of our ordinary shares issuable upon conversion the Convertible Notes;                                                  |
| ● | 37,516                                                                                                                               
 of our ordinary shares issuable upon conversion of convertible notes in the aggregate principal amount of $53,402 as of June 23,     
 2025 at a weighted-average exercise price of $1.42 per share; and                                                                    |
| ● | 4,458,625                                                                                                                            
 of our ordinary shares issuable upon exercise of an aggregate of 8,917,250 outstanding warrants at a weighted-average exercise price 
 of $11.50 per share.                                                                                                                 |

| S-4 |

<div align='center'>RISK FACTORS</div>

Investment in our ordinary shares involves risks. Before deciding whether to invest in our ordinary shares, you should consider carefully the risk factors discussed below and those contained in the section entitled “Risk Factors” contained in our Annual Report on Form 20-F for the fiscal year ended December 31, 2024, as filed with the SEC on April 29, 2025, which is incorporated herein by reference in its entirety, as well as any amendment or update to our risk factors reflected in subsequent filings with the SEC. If any of the risks or uncertainties described in our SEC filings actually occurs, our business, financial condition, results of operations, or cash flow could be materially and adversely affected. This could cause the trading price of our ordinary shares to decline, resulting in a loss of all or part of your investment. The risks and uncertainties we have described are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business operations.

Risks Related to our Business

Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability continue as a “going concern.”

The Company had a net loss of approximately $15.4 million and $10.0 million for the years ended December 31